Log In
BCIQ
Print this Print this
 

Hepatitis C vaccine

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionRecombinant hepatitis C virus (HCV) antigen with MF59 adjuvant
Molecular Target Not available
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationHepatitis C virus (HCV)
Indication DetailsPrevent hepatitis C virus (HCV) infection; Treat hepatitis C virus (HCV)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today